Eregli Demir Ve Celik Fabrikalari TAS is a Turkey-based company engaged in production of flat steel, long steel and other steel products... Show more
The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an uptrend is expected.
The RSI Indicator demonstrates that the ticker has stayed in the overbought zone for 14 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.
The Moving Average Convergence Divergence Histogram (MACD) for ERELY turned negative on February 03, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 18 similar instances when the indicator turned negative. In of the 18 cases the stock turned lower in the days that followed. This puts the odds of success at .
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.670) is normal, around the industry mean (1.572). P/E Ratio (37.678) is within average values for comparable stocks, (88.641). ERELY's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (2.143). Dividend Yield (0.010) settles around the average of (0.036) among similar stocks. ERELY's P/S Ratio (92.593) is very high in comparison to the industry average of (2.794).
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. ERELY’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ERELY’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 68, placing this stock worse than average.
Industry Steel
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| GLRIX | 24.06 | 0.02 | +0.08% |
| James Balanced: Golden Rainbow Instl | |||
| FFGIX | 25.17 | N/A | N/A |
| Fidelity Advisor Global Commodity Stk I | |||
| PACLX | 35.00 | -0.24 | -0.68% |
| T. Rowe Price Capital Appreciation Adv | |||
| HIAHX | 17.78 | -0.14 | -0.78% |
| Hartford Healthcare HLS IA | |||
| ICEQX | 22.70 | -0.28 | -1.22% |
| Nomura Core Equity Fund Class R6 | |||
A.I.dvisor tells us that ERELY and BLSFY have been poorly correlated (+11% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that ERELY and BLSFY's prices will move in lockstep.
| Ticker / NAME | Correlation To ERELY | 1D Price Change % | ||
|---|---|---|---|---|
| ERELY | 100% | N/A | ||
| BLSFY - ERELY | 11% Poorly correlated | N/A | ||
| BLSFF - ERELY | 7% Poorly correlated | -2.29% | ||
| ZKIN - ERELY | 2% Poorly correlated | -1.51% | ||
| ARCXF - ERELY | 0% Poorly correlated | N/A | ||
| AMSYF - ERELY | 0% Poorly correlated | N/A | ||
More | ||||